Author:
Shen Zhiyong,Xue Dong,Wang Kun,Zhang Facai,Shi Jiaqi,Jia Benzhong,Yang Dan,Zhang Qianjin,Zhang Shuai,Jiang Hongyu,Luo Daiqin,Li Xueying,Zhong Quliang,Zhang Junhao,Peng Zheng,Han Yu,Sima Chongyang,He Xiaozhou,Hao Lin
Abstract
Abstract
Background
To observe and explore the effect of metformin on the migration and proliferation of bladder cancer T24 and 5637 cells in vitro.
Methods
Bladder cancer T24 and 5637 cell lines were cultured in vitro, and were divided into group A (blank control group) and group B (metformin group: 5, 10, 15, and 20 mmol/L); both groups were plated on 6-well plates at the same time. Culture in 24-well plates was used for wound healing assays and in 96-well plates for Transwell migration and invasion, and Cell Counting Kit-8 proliferation experiments. We observed and detected the cell migration and proliferation ability of each group at 48 h, and calculated the cell migration area and survival rate. Flow cytometry was used to detect cell apoptosis in the groups. The apoptosis-related proteins, cleaved-caspase 3, cleaved-PARP, and the PI3K/AKT/mTOR signaling pathway member proteins PI3K, phosphorylated (p)-PI3K, AKT, p-AKT, mTOR, and p-mTOR were detected using western blotting.
Results
After 48 h of treatment with different concentrations of metformin, the cell migration and proliferation capabilities were significantly lower than those in the blank control group. The proliferation and migration abilities of T24 and 5637 cells decreased in a metformin concentration-dependent manner (P < 0.05). The apoptosis rate under different concentrations of metformin, as detected by flow cytometry, showed a significantly higher rate in the metformin group than in the control group (P < 0.05). Compared with that in the control group, the level of cleaved-caspase 3 and cleaved-PARP protein in the metformin group was increased in each treatment group, and the levels of p-mTOR, p-AKT, and p-PI3K decreased significantly compared with those in the control group (P < 0.05).
Conclusion
Metformin inhibited bladder cancer T24 and 5637 cell migration and proliferation, and induced their apoptosis. The mechanism might involve inhibition of the activation of the PI3K/AKT/mTOR signaling pathway.
Publisher
Springer Science and Business Media LLC
Subject
Urology,Reproductive Medicine,General Medicine
Reference30 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
2. Youyan G, Nianzeng X, Jianzhong S. The epidemiological status of urinary malignancies in China. Can Res. 2019;22(1):67–72.
3. Marcos-gragera R, Mallone S, Kiemeney LA. Urinary tract cancer survival in Europe 1999–2007: results of the population-based study EUROCARE-5. Eur J Cancer. 2015;51(15):2217–30.
4. EAU European Association of Urology. Guidelines non-muscle-invasive bladder cancer (TaT1 and CIS)(2019 edition)[DB/OL].
5. Richard J, Maurizio A, Wim J. Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate-and high-risk stage TaT1 urothelial carcinoma of the bladder. Eur Urol. 2010;57(5):766–73. https://doi.org/10.1016/j.eururo.2009.12.024.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献